Holen Sie sich die Stockscreener-App
1.88
6.21%
0.11
Vorhandelsmarkt:
1.90
0.02
+1.06%
Schlusskurs vom Vortag:
$1.77
Offen:
$1.78
24-Stunden-Volumen:
1.60M
Relative Volume:
0.85
Marktkapitalisierung:
$699.85M
Einnahmen:
$106.34M
Nettoeinkommen (Verlust:
$-74.66M
KGV:
-1.9789
EPS:
-0.95
Netto-Cashflow:
$-46.12M
1W Leistung:
-6.47%
1M Leistung:
-6.00%
6M Leistung:
-14.16%
1J Leistung:
-16.44%
1-Tages-Spanne:
$1.73
$1.885
1-Wochen-Bereich:
$1.67
$2.14
52-Wochen-Spanne:
$1.21
$3.04
Standard Biotools Inc Stock (LAB) Company Profile
Firmenname
Standard Biotools Inc
Sektor
Branche
Telefon
(650) 266-6000
Adresse
2 TOWER PLACE, SOUTH SAN FRANCISCO
Vergleichen Sie LAB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.88 | 699.85M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-16 | Eingeleitet | TD Cowen | Buy |
| 2024-04-04 | Eingeleitet | Jefferies | Buy |
| 2023-07-12 | Eingeleitet | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Aktie (LAB) Neueste Nachrichten
Appian, Bitfarms, Standard BioTools, and More Stocks See Action From Activist Investors - MSN
Standard BioTools (NASDAQ:LAB) Trading Down 5.8%Here's What Happened - MarketBeat
Standard BioTools stock soars on Q4 revenue beat By Investing.com - Investing.com South Africa
Standard BioTools stock soars on Q4 revenue beat - Investing.com India
Standard BioTools (NASDAQ:LAB) Shares Gap UpWhat's Next? - MarketBeat
Standard BioTools stock soars on upbeat preliminary 4Q revenue By Investing.com - Investing.com Canada
Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday - Benzinga
Standard BioTools Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2024 - Marketscreener.com
Standard BioTools Reports 2024 Revenue Achievements and Plans - TipRanks
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue - The Manila Times
In the wake of Standard BioTools Inc.'s (NASDAQ:LAB) latest US$52m market cap drop, institutional owners may be forced to take severe actions - Simply Wall St
Standard BioTools Hits Top-End Revenue Target of $174M, Slashes Operating Costs in 2024 - StockTitan
Standard BioTools announces CCO Jeremy Davis's departure By Investing.com - Investing.com Canada
Standard BioTools announces CCO Jeremy Davis's departure - Investing.com India
Standard BioTools Announces CCO Jeremy Davis’s Departure - TipRanks
Jane Street Group LLC Sells 60,340 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools SomaScan Assay Powers Key Insights into Semaglutide Treatment Published in Nature Medicine - The Manila Times
Principal Financial Group Inc. Has $43,000 Stock Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools' SomaScan Platform Breakthrough: Nature Medicine Study Reveals Semaglutide Insights - StockTitan
In the wake of Standard BioTools Inc.'s (NASDAQ:LAB) latest US$56m market cap drop, institutional owners may be forced to take severe actions - Yahoo Finance
Geode Capital Management LLC Buys 154,848 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools (NASDAQ:LAB) Stock Price Down 6.3%Should You Sell? - MarketBeat
Standard BioTools Inc. (NASDAQ:LAB) Shares Acquired by State Street Corp - MarketBeat
State Street Corp Purchases 1,157,984 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Position Decreased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Barclays PLC Purchases 377,195 Shares of Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Standard BioTools CEO to Present at J.P. Morgan Healthcare Conference 2024 - StockTitan
Standard BioTools (NASDAQ:LAB) Trading Down 6.8%Here's What Happened - MarketBeat
BNP Paribas Financial Markets Lowers Stock Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
After Leaping 35% Standard BioTools Inc. (NASDAQ:LAB) Shares Are Not Flying Under The Radar - Simply Wall St
Standard BioTools (NASDAQ:LAB) Shares Up 9.9%Still a Buy? - MarketBeat
What Are You Thinking About Investing In Standard BioTools Inc (NASDAQ: LAB) Stock? - Stocks Register
Charles Schwab Investment Management Inc. Purchases 1,597,728 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Shares Purchased by Charles Schwab Investment Management Inc. - MarketBeat
Standard BioTools (STU:FLB) Enterprise Value : €386.4 Mil (As of Nov. 30, 2024) - GuruFocus.com
LAB Stock Price and Chart — NASDAQ:LAB - TradingView
Standard BioTools Inc. (NASDAQ:LAB) Short Interest Down 24.9% in November - MarketBeat
Standard BioTools (NASDAQ:LAB) adds US$78m to market cap in the past 7 days, though investors from three years ago are still down 59% - Simply Wall St
Sumitomo Mitsui Trust Group Inc. Decreases Holdings in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Indaba Capital Management L.P. Acquires New Stake in Standard Bi - GuruFocus.com
Creative Planning Purchases Shares of 20,328 Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools names new CFO By Investing.com - Investing.com Australia
ARK Investment Management LLC Lowers Stock Holdings in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Standard BioTools (STU:FLB) Price-to-Operating-Cash-Flow : (As of Nov. 07, 2024) - GuruFocus.com
Standard BioTools (STU:FLB) Revenue per Share : €0.67 (TTM As of Sep. 2024) - GuruFocus.com
Standard BioTools appoints Kim as Chief Financial Officer - TipRanks
Standard BioTools names new CFO - Investing.com
Standard BioTools Names Alex Kim as New CFO - TipRanks
Finanzdaten der Standard Biotools Inc-Aktie (LAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):